Skip to main content
Clinical Trials/NCT01060449
NCT01060449
Completed
N/A

Stimulus Intensity in Left Ventricular Leads and Response to Cardiac Resynchronization Therapy

Emory University1 site in 1 country60 target enrollmentAugust 2008

Overview

Phase
N/A
Intervention
Not specified
Conditions
Congestive Heart Failure
Sponsor
Emory University
Enrollment
60
Locations
1
Primary Endpoint
Ejection Fraction
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

Cardiac resynchronization therapy (CRT) is a device implanted to improve the function of some people's hearts. CRT involves the placement of 3 wires in the heart through a vein near the front of your left or right shoulder into three pumping chambers of the heart, the most important being the left lower chamber, left ventricle (LV).

Detailed Description

The purpose of Cardiac resynchronization therapy (CRT) is to send small amounts of energy (called pacing) through the wires to both the left and right lower chambers of your heart at (or near) the same time. This helps the heart pump in a more coordinated way and send more blood to your body with each beat. How much energy is used for pacing is called the stimulus intensity. Increasing the pacing stimulus intensity of the left ventricular wire can lead to an increase in the volume of heart muscle directly stimulated. This has previously been shown to produce beneficial effects on the heart function, like strength of contraction and increased volume of blood pumped. The purpose of this study is to determine if pacing the wires in the left ventricular chamber of the heart using higher stimulus intensity improves the strength of the heart's contraction.

Registry
clinicaltrials.gov
Start Date
August 2008
End Date
February 2012
Last Updated
12 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Michael S. Lloyd

Principal Investigator

Emory University

Eligibility Criteria

Inclusion Criteria

  • Adults who fulfill approved criteria to receive a cardiac resynchronization device.

Exclusion Criteria

  • Adults who are unable to give informed consent.

Outcomes

Primary Outcomes

Ejection Fraction

Time Frame: 6 months

Secondary Outcomes

  • Quality of Life(6 months)
  • Six minute hall walk(6 months)
  • End diastolic dimension(6 months)

Study Sites (1)

Loading locations...

Similar Trials